SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) June 2, 2000
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
2275 Swallow Hill Road, Bldg. 2500
Pittsburgh, Pennsylvania 15220
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
Former address: 300 Indian Springs Road; Indiana,
Pennsylvania 15701
____________________________________________________________
_____
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
Biocontrol Technology, Inc. announced today that
it plans to change its name to BICO and will form
a new division that will focus on the
Corporation's biomedical projects. The new
division, which will retain the name Biocontrol
Technology, will be headed by David L. Purdy and
will be headquartered in Indiana, Pennsylvania.
Item 6. Resignation of Registrant's Directors.
David L. Purdy resigned as Chairman and a director
of the Corporation in order to head its new
division. (Resignation letter attached as an
exhibit)
Item 7. Financial Statement, Pro Forma Financial Information and Exhibits.
(a) Financial Statements and Businesses Acquired - Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits
i.Press Release
ii. David L. Purdy resignation letter
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: June 2, 2000
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
BIOCONTROL TECHNOLOGY TO CHANGE NAME TO BICO;
DAVID L. PURDY TO HEAD NEW DIVISION
Pittsburgh, PA - June 2, 2000 - Biocontrol Technology,
Inc. (OTCBB:BICO) announced today that the Company plans to
change its name to BICO, and will create a new division that
will retain the name Biocontrol Technology. The new
division, which will be headquartered at its Indiana, PA
location, will concentrate on the Company's biomedical
projects, including the research, development and
manufacturing of the Company's biomedical products.
The Company's Chairman, David L. Purdy, will resign his
position as a director and Chairman of the Board in order to
become the President and CEO of the new division so he can
focus his full-time efforts and energy on the continued
development and refinement of the Diasensor, the Company's
noninvasive glucose sensor. He will also remain the
Chairman of the Board of Diasensor.com, Inc.
Biocontrol Technology has its corporate offices in
Pittsburgh, PA and is involved in the development and
manufacture of biomedical devices and environmental
products. The company's subsidiaries include Diasensor.com,
ViaCirQ, Inc. and Petrol Rem, Inc. All are located in
Pittsburgh, PA.
WEB SITE: www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER: 1-800-357-6204
This press release contains statements of a forward-looking
nature. Shareholders and potential investors are cautioned
that such statements are predictions and actual events or
results may vary significantly.
###
1482 Ambrose Road
Marion Center, PA 15759
724-397-2779
June 1, 2000
To the Board of Directors of Biocontrol Technology, Inc.
Gentlemen:
Please accept my resignation as a member and Chairman of the
Board of Directors of Biocontrol Technology, Inc.
I am resigning in order to focus my efforts and energy on
our new division, Biocontrol Technology, and on our
biomedical products.
Sincerely,
/s/ David L. Purdy
David L. Purdy